These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8182419)

  • 1. Nurses and clinical trials.
    Snyder SL
    J Cardiovasc Nurs; 1994 Jan; 8(2):86-90. PubMed ID: 8182419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The drug research process.
    Jorgensen H; Harris JS
    Dermatol Nurs; 1992 Dec; 4(6):469-75. PubMed ID: 1286003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical nurse specialist as research coordinator in clinical drug trials.
    Raybuck JA
    Clin Nurse Spec; 1997 Jan; 11(1):15-9. PubMed ID: 9233133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. U.S. FDA regulatory challenges and review.
    Lepore P
    Qual Assur; 1994 Jun; 3(2):131-7. PubMed ID: 7804628
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical research and the development of new drugs: issues for nurses.
    Holaday B; Mills DM
    Dimens Crit Care Nurs; 2004; 23(4):179-86. PubMed ID: 15273487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Issues in clinical trial design from the FDA perspective.
    Katz R
    Epilepsia; 2003; 44 Suppl 7():9-15. PubMed ID: 12919333
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulatory and scientific issues regarding use of foreign data in support of new drug applications in the United States: an FDA perspective.
    Khin NA; Yang P; Hung HM; Maung-U K; Chen YF; Meeker-O'Connell A; Okwesili P; Yasuda SU; Ball LK; Huang SM; O'Neill RT; Temple R
    Clin Pharmacol Ther; 2013 Aug; 94(2):230-42. PubMed ID: 23588316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory and scientific issues in studies to evaluate sexual dysfunction in antidepressant drug trials.
    Khin NA; Kronstein PD; Yang P; Ishida E; Hung HM; Mathis MV; Unger EF; Temple RJ
    J Clin Psychiatry; 2015 Aug; 76(8):1060-3. PubMed ID: 26214346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory pathways to the market: an overview.
    Morton WA
    Artif Organs; 1982 Nov; 6(4):463-9. PubMed ID: 6762190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial design issues in schizophrenic research.
    Casey DE
    J Clin Psychiatry; 2001; 62 Suppl 9():17-20; discussion 21-2. PubMed ID: 11379826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA explores new antiretroviral trial designs: interview with David Feigal, M.D. Interview by John S. James.
    Feigal D
    AIDS Treat News; 1997 Jun; (No 273):1-5. PubMed ID: 11364399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an FDA guidance document for clinical trials in SLE.
    Siegel JN
    Lupus; 1999; 8(8):581-5. PubMed ID: 10568893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FDA and designing clinical trials for chronic cutaneous ulcers.
    Maderal AD; Vivas AC; Eaglstein WH; Kirsner RS
    Semin Cell Dev Biol; 2012 Dec; 23(9):993-9. PubMed ID: 23063664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Issues in regulatory guidelines for data monitoring committees.
    DeMets D; Califf R; Dixon D; Ellenberg S; Fleming T; Held P; Julian D; Kaplan R; Levine R; Neaton J; Packer M; Pocock S; Rockhold F; Seto B; Siegel J; Snapinn S; Stump D; Temple R; Whitley R
    Clin Trials; 2004; 1(2):162-9. PubMed ID: 16281888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The design of clinical trials in psoriasis: lessons for clinical practice.
    Feldman SR
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S62-5. PubMed ID: 12894128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nurses' guide to the drug development process and the current regulatory environment.
    Leach EE
    Dermatol Nurs; 1993 Oct; 5(5):351-6. PubMed ID: 8274343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. United States Food and Drug Administration Regulation of Gene and Cell Therapies.
    Bailey AM; Arcidiacono J; Benton KA; Taraporewala Z; Winitsky S
    Adv Exp Med Biol; 2015; 871():1-29. PubMed ID: 26374210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the FDA Amendment Act with trial registration, publication, and outcome reporting.
    Phillips AT; Desai NR; Krumholz HM; Zou CX; Miller JE; Ross JS
    Trials; 2017 Jul; 18(1):333. PubMed ID: 28720112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An FDA Viewpoint on Unique Considerations for Medical-Device Clinical Trials.
    Faris O; Shuren J
    N Engl J Med; 2017 Apr; 376(14):1350-1357. PubMed ID: 28379790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.